Article Details

AstraZeneca expands global footprint in rare disease with availability of first Alexion ... - Cision News

Retrieved on: 2022-11-11 07:19:06

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca expands global footprint in rare disease with availability of first Alexion ... - Cision News. View article details on hiswai:

Excerpt

AstraZeneca today announced the availability of the first rare disease therapy from Alexion, AstraZeneca's Rare Disease group, in China.

Article found on: news.cision.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up